CSI Market
Sign In | Register

Enfusion inc (ENFN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ENFN Annual Cash Flow →
Cash flow data covering Enfusion inc–Dec 31 2023 offers a view into how Dec 31 2024's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income3.92
Depreciation & amortization11.75
Amortization of Other Assets0.23
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.23
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation19.03
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Increase Decrease In Operating Lease Liability5.55
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-0.47
Increase (Decrease) in Accounts Payable-1.19
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities2.68
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-4.79
Other Working Capital2.17
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities7.38
Discontinued operations0.00
Net Cash flow from Operating Activities34.68
Investing Activities
Capital Expenditures-3.64
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Capitalized Computer Software Period Increase Decrease-5.49
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable-3.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-13.89
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-0.14
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-37.83
Payment For Redemption Of Common Limited Partners Units-
Payment For Purchase Of Common Units-
Receipt Of Tax Refund-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents35.60
Employee Benefits And Share Based Compensation Noncash0.78
Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Paid0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-1.40
Effect of exchange rate on cash flow-0.51
Discontinued operations0.00
Free Cash Flow31.05
Total Cash Flow18.88
4 historic quarters locked

Sign in to unlock the full Enfusion inc cash flow history.

Sign In Create Free Account

About Enfusion Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-24-014265

Figures are derived from filed reports and may be restated. Historical data is subject to revision.